Śmigiel R, Królak-Olejnik B, Śniegórska D, Rozensztrauch A, Szafrańska A, Sasiadek M M, Wertheim-Tysarowska K
Department of Pediatrics, Wroclaw Medical University, Wroclaw, Poland.
Department of Neonatology, Wroclaw Medical University, Wroclaw, Poland.
Balkan J Med Genet. 2017 Mar 4;19(2):81-84. doi: 10.1515/bjmg-2016-0040. eCollection 2016 Dec 1.
Netherton Syndrome (NS) is a very rare genetic skin disease resulting from defects in the gene (encoding the protease inhibitor lympho-epithelial Kazal type inhibitor 1, LEKTI1). In this report, we provide a detailed clinical description of a Polish patient with two mutations, the novel c.1816_1820+21delinsCT and possibly recurrent c.1431-12G>A. A detailed pathogenesis of Netherton Syndrome, on the basis of literature review, is discussed in the view of current knowledge about the LEKT1 molecular processing and activity.
Netherton综合征(NS)是一种非常罕见的遗传性皮肤病,由基因缺陷(编码蛋白酶抑制剂淋巴细胞上皮Kazal型抑制剂1,LEKTI1)引起。在本报告中,我们详细描述了一名患有两种突变的波兰患者,新发现的c.1816_1820+21delinsCT和可能复发性的c.1431-12G>A。基于文献综述,结合目前对LEKT1分子加工和活性的了解,讨论了Netherton综合征的详细发病机制。